News
HSIC
73.94
+1.23%
0.90
Assessing Henry Schein (HSIC) Valuation As Recent Share Price Moves Draw Fresh Attention
Simply Wall St · 1d ago
3 Healthcare Stocks with Open Questions
Barchart · 2d ago
Analysts Offer Insights on Healthcare Companies: Bicara Therapeutics Inc. (BCAX), Spyre Therapeutics (SYRE) and Henry Schein (HSIC)
TipRanks · 3d ago
Weekly Report: what happened at HSIC last week (0323-0327)?
Weekly Report · 4d ago
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Encompass Health (EHC) and Merck & Company (MRK)
TipRanks · 5d ago
How Investors May Respond To Henry Schein (HSIC) Strong Q4 Specialty Products-Driven Margin Expansion
Simply Wall St · 03/26 15:07
Should You Retain Henry Schein Stock in Your Portfolio for Now?
NASDAQ · 03/26 12:14
Align Technology: Only International Growth Can Save Them Now (Downgrade)
Seeking Alpha · 03/24 12:15
Is Henry Schein Stock Underperforming the S&P 500?
Barchart · 03/24 08:46
Weekly Report: what happened at HSIC last week (0316-0320)?
Weekly Report · 03/23 10:11
Assessing Whether Henry Schein (HSIC) Shares Look Undervalued After Recent Weak Momentum
Simply Wall St · 03/23 09:06
Citi's top large-cap stocks with positive ROE trends
Seeking Alpha · 03/22 13:54
Top Henry Schein Executive Makes Notable Insider Stock Move
TipRanks · 03/21 02:02
Henry Schein Products CEO Thomas C. Popeck disposes of USD 99,000 in Henry Schein common shares
Reuters · 03/20 20:08
Barclays Sticks to Their Buy Rating for Henry Schein (HSIC)
TipRanks · 03/20 07:21
Ethisphere Names Henry Schein as One of the 2026 World's Most Ethical Companies® for 15th Consecutive Year
Barchart · 03/18 05:30
Piper Sandler Reaffirms Their Buy Rating on Henry Schein (HSIC)
TipRanks · 03/17 11:26
Weekly Report: what happened at HSIC last week (0309-0313)?
Weekly Report · 03/16 10:11
Henry Schein: Still A Buy - But Caution Is Warranted
Seeking Alpha · 03/12 14:17
Insider Move at Henry Schein Sparks Fresh Buzz Among Investors
TipRanks · 03/12 02:01
More
Webull provides a variety of real-time HSIC stock news. You can receive the latest news about Henry Schein, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About HSIC
Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.